1. Home
  2. MRSN vs MOBX Comparison

MRSN vs MOBX Comparison

Compare MRSN & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • MOBX
  • Stock Information
  • Founded
  • MRSN 2001
  • MOBX 2020
  • Country
  • MRSN United States
  • MOBX United States
  • Employees
  • MRSN N/A
  • MOBX N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • MRSN Health Care
  • MOBX
  • Exchange
  • MRSN Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • MRSN 37.0M
  • MOBX 43.8M
  • IPO Year
  • MRSN 2017
  • MOBX N/A
  • Fundamental
  • Price
  • MRSN $7.24
  • MOBX $0.89
  • Analyst Decision
  • MRSN Strong Buy
  • MOBX
  • Analyst Count
  • MRSN 4
  • MOBX 0
  • Target Price
  • MRSN $63.67
  • MOBX N/A
  • AVG Volume (30 Days)
  • MRSN 138.9K
  • MOBX 325.5K
  • Earning Date
  • MRSN 08-13-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • MRSN N/A
  • MOBX N/A
  • EPS Growth
  • MRSN N/A
  • MOBX N/A
  • EPS
  • MRSN N/A
  • MOBX N/A
  • Revenue
  • MRSN $34,769,000.00
  • MOBX $10,984,000.00
  • Revenue This Year
  • MRSN N/A
  • MOBX N/A
  • Revenue Next Year
  • MRSN $1.03
  • MOBX N/A
  • P/E Ratio
  • MRSN N/A
  • MOBX N/A
  • Revenue Growth
  • MRSN 16.14
  • MOBX 180.13
  • 52 Week Low
  • MRSN $5.21
  • MOBX $0.55
  • 52 Week High
  • MRSN $70.75
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 48.99
  • MOBX 49.79
  • Support Level
  • MRSN $5.21
  • MOBX $0.84
  • Resistance Level
  • MRSN $7.68
  • MOBX $0.99
  • Average True Range (ATR)
  • MRSN 0.54
  • MOBX 0.09
  • MACD
  • MRSN 0.12
  • MOBX -0.01
  • Stochastic Oscillator
  • MRSN 81.04
  • MOBX 51.11

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: